No post found
search
RECENT POSTS
- Cyrus Biotechnology to Present Its Novel IgG-degrading IdeS Enzyme Development Candidates for Autoimmune Indications at PepTalk Conference in San Diego
- The future of AI in biologics drug discovery
- The impact of new protein AI tools on real-world biologics discovery
- Cyrus Biotechnology Scientist Erik Procko and the company’s lead ACE2-Fc Fusion protein COVID-19 therapeutic are featured in Science news article highlighting the exciting potential of decoy receptor drugs in fighting SARS-CoV-2, and other viral infections – (Science.com)
- OpenFold AI Research Consortium Welcomes 4 New Members: Bayer, Dassault, CHARM Therapeutics and BaseCamp Research
ARCHIVES
CATEGORIES
sign up for our newsletter now!
RECENT COMMENTS